宜宾割双眼皮到哪里好宜宾假体隆胸好的医院,膨体隆鼻在宜宾哪家好,宜宾玻尿酸隆鼻有效期,宜宾整型双眼皮绣眉什么价,在宜宾去眼袋哪里效果好,宜宾哪里双眼皮整形好,宜宾割一只双眼皮要多少钱

US Customs and Border Protection will not vaccinate migrants, even though three children who had been in US custody died after contracting the flu.The cases all occurred since December."In general, due to the short-term nature of CBP holding and the complexities of operating vaccination programs, neither CBP nor its medical contractors administer vaccinations to those in our custody," according to a statement Tuesday from CBP.Migrants are supposed to held in CBP custody for 72 hours or less, but often remain there for longer.After leaving CBP custody, children without parents are sent into the care of the US Department of Health and Human Services, where flu vaccines are distributed, according to Evelyn Stauffer, a spokeswoman for the Office of Refugee Resettlement, a part of HHS.Public health experts had strong reactions to CBP's statement, saying the department should be able to vaccinate migrants, even if they're in CBP custody for only a few days."I think their answer is completely inappropriate," said Dr. William Schaffner, an infectious disease specialist at Vanderbilt University and an adviser the US Centers for Disease Control and Protection. "They ought to be able to do this. They create facilities that encourage the spread of infectious agents, with flu at the top of the list."Flu activity in the United States typically begins to increase around October and many US pharmacies already have flu vaccines available.Children younger than 5, and especially those younger than 2, are at high risk of serious flu-related complications, according to the CDC. Flu seasons vary in severity, but thousands of children are hospitalized each year related to the flu, and some children die. A flu vaccine offers the best defense against getting flu and spreading it to others, the CDC said.Concern about contagious diseasesOn August 5, two members of Congress 1891

Washington state Gov. Jay Inslee announced Friday that he is running for President, launching a bid in which he intends to make combating climate change the central rationale for his campaign.Inslee announced the 225

Vaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what’s causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes.The ailment has sickened at least 530 people and killed nine. Some vaped nicotine, but many reported using oil containing THC, marijuana’s high-inducing ingredient, and said they bought products from pop-up shops and other illegal sellers. The only death linked to THC vapes bought at legal shops occurred in Oregon.Amid the health scare, the amount of the legal pot industry’s revenue that comes from vape products has dropped by 15% nationwide, with some states, including Oregon, seeing decreases of more than 60%.Health officials in California, home to the world’s largest legal marijuana marketplace, this week issued an advisory urging people to stop all forms of vaping until a cause is determined. Massachusetts, which like California allows so-called recreational use of marijuana by people 21 and older, went further than any other state, issuing a four-month ban on vape sales.Vaping THC is popular for those who want a quick high but don’t want the smoke that comes from lighting up a joint. Marijuana companies are trying to boost the public’s confidence by promoting that their vaping products are tested by the government, demanding ingredient lists from their vendors and in some cases pulling items from shelves. Some also are scrambling to get liability insurance.Still, many have seen notable declines in sales in the few weeks since the health scare emerged on a national scale.“It’s having an impact on how consumers are behaving,” said David Alport, owner of Bridge City Collective in Portland, which in two weeks saw a 31% drop in sales of vape cartridges that hold the oil that vaporizes when heated. “People are concerned, and we’re concerned.”In the United States’ booming legal cannabis market, vaping products have exploded in popularity. In roughly two years, they have grown from a small fraction of overall sales to about one-third, with .6 billion in sales between 2017 and 2019, according to New Frontier Data, an economic analysis firm that tracks the industry. About one-fifth of U.S. cannabis consumers report using them.New Frontier found a 15% decline in the market share for vape sales nationwide during the first week of September and saw no rebound in data collected through Sept. 18. At the state level, New Mexico, Massachusetts, Nevada and Montana all saw drops of one-third or more, while California fell by 6%. Oregon, which announced its death at the beginning of the month and said it was from a vape purchased at a regulated dispensary, saw one of the biggest drops in market share for vape revenue — 62%, said John Kagia, the firm’s chief knowledge officer. Analysts are watching to see if further erosion occurs following congressional testimony Tuesday by Dr. Anne Schuchat, principal deputy director of the U.S. Centers for Disease Control and Prevention, who said the number of lung illnesses could soon climb by the hundreds.“This is a very, very fast-moving issue, and it will likely be a couple more weeks, if not months, before we understand the impact it’s really had on the retail ecosystem and on consumers’ attitudes,” Kagia said.In an explosively growing market, “it’s not unexpected that something would come up that would be disruptive,” he said. “But the question is, how quick is the industry’s response and how agile is that response to assure the public and regulators that this issue is being addressed and there’s robust self-governance?”Doctors have said the illnesses resemble an inhalation injury, with the lungs apparently reacting to a caustic substance. So far, no single vaping product or ingredient has been linked to the illnesses. Some patients who have vaped only nicotine also have gotten ill.Health officials in New York are focusing on vitamin E acetate, a viscous solution that’s sometimes added to marijuana oils. Retailers in some markets are pulling products from their shelves that contain that and other additives. Other companies have proactively released public statements saying their vape oils contain only pure THC.In Illinois, a message board for medical marijuana patients banned posters from sharing home vape recipes.“I just do THC. No flavor additives. I won’t even take that chance,” said Lisa Haywood, a medical marijuana card holder who lives outside Chicago and follows the board for advice and support.Other medical marijuana users are worried about restrictions on vaping.If there’s a ban, “what does it do for all these people who have been seeing relief? ... It is going to really impact patients and the industry that we’ve fought” to create, said Melanie Rose Rodgers, a Colorado medical cannabis patient and a leader of the state’s chapter of Americans for Safe Access, which advocates for medical marijuana patients.State regulators track the cannabis sold to consumers but don’t monitor what additives, if any, are in marijuana oil vapes. That’s led states to begin discussions of how to tighten restrictions on vaping products even as retailers themselves try to determine which of the products on their shelves contain so-called cutting agents.“We haven’t evolved our system that far to think about what we would test for in those products. A lot of these additives were conceptual at the time when the (marijuana legalization) law passed and the program came into place,” said Steve Marks, executive director of the Oregon Liquor License Commission, which oversees the state’s cannabis industry.“Figuring that out is part of the evolution that we have to do as a consumer protection agency,” he said. “Science is not going to guide us because science is lagging.”Hilary Bricken, a Los Angeles-based attorney whose firm specializes in cannabis business law and regulatory issues, said the legal marijuana industry is moving so fast that many states are “literally making this up as they go,” and the vaping scare has stripped away the sense of security that consumers get from buying from a licensed dispensary.The vaping crisis will undoubtedly hasten tighter regulation at the state level and force the industry to patrol itself better to avoid crippling lawsuits, she said.Bobby Burleson, an analyst with Toronto-based investment and financial services company Canaccord Genuity, said the initial problems for the vape segment of the cannabis industry should moderate, and the health scare may in the end help the legal marijuana industry.The crisis “should ultimately accelerate the shift away from the black market for cannabis products in the U.S.,” he said.___Flaccus and Peltz, who reported from New York City, are members of AP’s marijuana beat team. Follow the AP’s complete marijuana coverage: 6895

UNLV is on normal schedule today. Please be safe and allow extra time for your commute. Students who are unable to get to class should contact their instructor regarding making up class work.Visit https://t.co/IeDE4RbAza for updates.— UNLV Police Services (@UNLVPD) February 21, 2019 295

WASHINGTON, D.C. – The House of Representatives approved a resolution that appointed seven House Democrats as impeachment managers and sent articles of impeachment against President Donald Trump to the Senate.The vote came hours after House Speaker Nancy Pelosi named U.S. Representatives Adam Schiff (D-California), Jerry Nadler (D-New York), Zoe Lofgren (D-California), Hakeem Jeffries (D-New York), Val Demings (D-Florida), Jason Crow (D-Colorado) and Sylvia Garcia (D-Texas as impeachment managers in the Senate trial that will decide President Donald Trump's fate.The articles are expected to be delivered to the Senate at 5 p.m.Senate Majority Leader Mitch McConnell (R-Kentucky) is expected to move ahead quickly with an impeachment trial. McConnell told reporters Tuesday that he fully expects the trial to be underway by next Tuesday.McConnell has said he will hold a full trial instead of merely voting to dismiss the articles. However, he is expected to formally approve ground rules for the trial without Democrat support and without first approving a witness list.The House voted to impeach Trump on the two counts in December. Pelosi had previously said she would not send articles of impeachment over to the Senate until she was assured that a fair trial would be conducted.House Democrats allege that Trump abused his power by withholding taxpayer funds earmarked for defense in Ukraine in exchange for Ukranian President Volodymyr Zelensky announcing an investigation into potential corruption regarding Joe Biden's son, who sat on the board for a Ukranian energy company. Hunter Biden has not faced any corruption charges in Ukraine or the United States. House Democrats also allege Trump obstructed Congress by not participating in impeachment proceedings against him. 1799